Back to top

Calamos Holdings, Inc. $150,000,000 5.24% Senior Notes due 2011 NOTE PURCHASE AGREEMENT

Note Purchase Agreement

Calamos Holdings, Inc. $150,000,000 5.24% Senior Notes due 2011 NOTE PURCHASE AGREEMENT | Document Parties: Calamos Holdings, Inc | CALAMOS ASSET MANAGEMENT, INC. You are currently viewing:
This Note Purchase Agreement involves

Calamos Holdings, Inc | CALAMOS ASSET MANAGEMENT, INC.

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: Calamos Holdings, Inc. $150,000,000 5.24% Senior Notes due 2011 NOTE PURCHASE AGREEMENT
Governing Law: New York     Date: 12/29/2008
Industry: Investment Services     Law Firm: Gardner Carton;Shearman Sterling     Sector: Financial

Calamos Holdings, Inc. $150,000,000 5.24% Senior Notes due 2011 NOTE PURCHASE AGREEMENT, Parties: calamos holdings  inc , calamos asset management  inc.
50 of the Top 250 law firms use our Products every day

Exhibit 4.1 EXECUTION COPY   Calamos Holdings, Inc. $150,000,000 5.24% Senior Notes due 2011 NOTE PURCHASE AGREEMENT Dated April 29, 2004  

 




 

TABLE OF CONTENTS

 

 

 

 

 

Section

 

Page

 

 

 

 

 

1. AUTHORIZATION OF NOTES

 

 

1

 

 

 

 

 

 

2. SALE AND PURCHASE OF NOTES

 

 

1

 

 

 

 

 

 

3. CLOSING

 

 

1

 

 

 

 

 

 

4. CONDITIONS TO CLOSING

 

 

2

 

 

 

 

 

 

4.1. Representations and Warranties

 

 

2

 

4.2. Performance; No Default

 

 

2

 

4.3. Compliance Certificates

 

 

2

 

4.4. Opinions of Counsel

 

 

2

 

4.5. Purchase Permitted By Applicable Law, etc.

 

 

3

 

4.6. Sale of Other Notes

 

 

3

 

4.7. Payment of Special Counsel Fees

 

 

3

 

4.8. Private Placement Number

 

 

3

 

4.9. Changes in Corporate Structure

 

 

3

 

4.10. Proceedings and Documents

 

 

3

 

 

 

 

 

 

5. REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

 

4

 

 

 

 

 

 

5.1. Organization; Power and Authority

 

 

4

 

5.2. Authorization, etc.

 

 

4

 

5.3. Disclosure

 

 

4

 

5.4. Organization and Ownership of Shares of Subsidiaries; Affiliates

 

 

5

 

5.5. Financial Statements

 

 

6

 

5.6. Compliance with Laws, Other Instruments, etc.

 

 

6

 

5.7. Governmental Authorizations, etc.

 

 

6

 

5.8. Litigation; Observance of Agreements, Statutes and Orders

 

 

6

 

5.9. Taxes

 

 

7

 

5.10. Title to Property; Leases

 

 

7

 

5.11. Licenses, Permits, etc.

 

 

7

 

5.12. ERISA

 

 

8

 

5.13. Private Offering by the Company

 

 

8

 

5.14. Use of Proceeds; Margin Regulations

 

 

8

 

5.15. Existing Indebtedness; Future Liens

 

 

9

 

5.16. Foreign Assets Control Regulations, etc.

 

 

9

 

5.17. Status under Certain Statutes

 

 

9

 

5.18. Environmental Matters

 

 

9

 

5.19. Pari Passu Ranking

 

 

10

 

 

 

 

 

 

6. REPRESENTATIONS OF THE PURCHASER

 

 

10

 

 

 

 

 

 

6.1. Purchase for Investment

 

 

10

 

6.2. Source of Funds

 

 

10

 

 


 

 

 

 

 

 

Section

 

Page

 

 

 

 

 

7. INFORMATION AS TO COMPANY

 

 

11

 

 

 

 

 

 

7.1. Financial and Business Information

 

 

11

 

7.2. Officer’s Certificate

 

 

13

 

7.3. Inspection

 

 

14

 

 

 

 

 

 

8. PREPAYMENT OF THE NOTES

 

 

15

 

 

 

 

 

 

8.1. No Scheduled Prepayments

 

 

15

 

8.2. Optional Prepayments with Make-Whole Amount

 

 

15

 

8.3. Mandatory Offer to Prepay upon a Change of Control

 

 

15

 

8.4. Allocation of Partial Prepayments

 

 

16

 

8.5. Maturity; Surrender, etc.

 

 

17

 

8.6. Purchase of Notes

 

 

17

 

 

 

 

 

 

9. AFFIRMATIVE COVENANTS

 

 

17

 

 

 

 

 

 

9.1. Compliance with Law

 

 

17

 

9.2. Insurance

 

 

17

 

9.3. Maintenance of Properties

 

 

18

 

9.4. Payment of Taxes and Claims

 

 

18

 

9.5. Corporate Existence, etc.

 

 

18

 

9.6. Ranking

 

 

18

 

 

 

 

 

 

10. NEGATIVE COVENANTS

 

 

18

 

 

 

 

 

 

10.1. Maintenance of Consolidated Net Worth

 

 

19

 

10.2. Consolidated Total Debt Leverage Ratio

 

 

19

 

10.3. Interest Coverage Ratio

 

 

19

 

10.4. Limitation on Subsidiary Indebtedness

 

 

19

 

10.5. Liens

 

 

20

 

10.6. Transactions with Affiliates

 

 

22

 

10.7. Nature of Business

 

 

22

 

10.8. Merger, Consolidation, etc.

 

 

22

 

 

 

 

 

 

11. EVENTS OF DEFAULT

 

 

23

 

 

 

 

 

 

12. REMEDIES ON DEFAULT, ETC.

 

 

25

 

 

 

 

 

 

12.1. Acceleration

 

 

25

 

12.2. Other Remedies

 

 

26

 

12.3. Rescission

 

 

26

 

12.4. No Waivers or Election of Remedies, Expenses, etc.

 

 

26

 

 

 

 

 

 

13. REGISTRATION; EXCHANGE; SUBSTITUTION OF NOTES

 

 

26

 

 

 

 

 

 

13.1. Registration of Notes

 

 

26

 

13.2. Transfer and Exchange of Notes

 

 

27

 

13.3. Replacement of Notes

 

 

27

 

 

 

 

 

 

14. PAYMENTS ON NOTES

 

 

28

 

14.1. Place of Payment

 

 

28

 

14.2. Home Office Payment

 

 

28

 

 ii

 


 

 

 

 

 

 

Section

 

Page

 

 

 

 

 

15. EXPENSES, ETC.

 

 

28

 

 

 

 

 

 

15.1. Transaction Expenses

 

 

28

 

15.2. Survival

 

 

29

 

 

 

 

 

 

16. SURVIVAL OF REPRESENTATIONS AND WARRANTIES; ENTIRE AGREEMENT

 

 

29

 

 

 

 

 

 

17. AMENDMENT AND WAIVER

 

 

29

 

 

 

 

 

 

17.1. Requirements

 

 

29

 

17.2. Solicitation of Holders of Notes

 

 

29

 

17.3. Binding Effect, etc.

 

 

30

 

17.4. Notes Held by Company, etc.

 

 

30

 

 

 

 

 

 

18. NOTICES

 

 

30

 

 

 

 

 

 

19. REPRODUCTION OF DOCUMENTS

 

 

31

 

 

 

 

 

 

20. CONFIDENTIAL INFORMATION

 

 

31

 

 

 

 

 

 

21. SUBSTITUTION OF PURCHASER

 

 

32

 

 

 

 

 

 

22. MISCELLANEOUS

 

 

32

 

 

 

 

 

 

22.1. Successors and Assigns

 

 

32

 

22.2. Payments Due on Non-Business Days

 

 

32

 

22.3. Severability

 

 

33

 

22.4. Construction

 

 

33

 

22.5. Counterparts

 

 

33

 

22.6. Governing Law

 

 

33

 

 

 

 

 

 

SCHEDULE A

 

 

Information Relating to Purchasers

 

 

 

 

 

SCHEDULE B 

 

 

Defined Terms

 

       

SCHEDULE 4.9 

 

 

Changes in Corporate Structure

 

       

SCHEDULE 5.3 

 

 

Disclosure Materials

 

       

SCHEDULE 5.4 

 

 

Subsidiaries of the Company and Ownership of Subsidiary Stock

 

       

SCHEDULE 5.5 

 

 

Financial Statements

 

       

SCHEDULE 5.7 

 

 

Governmental Authorizations, etc.

 

       

SCHEDULE 5.8

 

 

Certain Litigation

 iii

 


 

 

 

 

 

 

SCHEDULE 5.11 

 

 

Patents, etc.

 

       

SCHEDULE 5.14 

 

 

Use of Proceeds

 

       

SCHEDULE 5.15 

 

 

Existing Indebtedness

 

       

SCHEDULE 10.5 

 

 

Liens

 

       

EXHIBIT 1 

 

 

Form of 5.24% Senior Note due April 29, 2011

 

       

EXHIBIT 4.4(a) 

 

 

Form of Opinion of Special Counsel for the Company

 

       

EXHIBIT 4.4(b)

 

 

Form of Opinion of Special Counsel for the Purchasers

 iv

 




 

CALAMOS HOLDINGS, INC.
1111 East Warrenville Road
Naperville, Illinois 60563-1463 5.24% Senior Notes due 2011 April 29, 2004 TO EACH OF THE PURCHASERS LISTED IN      THE ATTACHED SCHEDULE A: Ladies and Gentlemen:           Calamos Holdings, Inc., a Delaware corporation (the "Company" ), agrees with you as follows: 1. AUTHORIZATION OF NOTES.           The Company has authorized the issue and sale of $150,000,000 aggregate principal amount of its 5.24% Senior Notes due April 29, 2011 (the "Notes" , such term to include any such notes issued in substitution therefor pursuant to Section 13 of this Agreement). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by you and the Company. Certain capitalized terms used in this Agreement are defined in Schedule B; references to a "Schedule" or an "Exhibit" are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. 2. SALE AND PURCHASE OF NOTES.           Subject to the terms and conditions of this Agreement, the Company will issue and sell to you and each of the other purchasers named in Schedule A (the "Other Purchasers" ), and you and the Other Purchasers will purchase from the Company, at the Closing provided for in Section 3, Notes in the principal amount specified opposite your names in Schedule A at the purchase price of 100% of the principal amount thereof. Your obligations hereunder and the obligations of the Other Purchasers are several and not joint obligations and you shall have no obligation and no liability to any Person for the performance or non-performance by any Other Purchaser. 3. CLOSING.           The sale and purchase of the Notes to be purchased by you and the Other Purchasers shall occur at the offices of Gardner Carton & Douglas, 191 North Wacker Drive, Suite 3700, Chicago, Illinois 60606-1698, at 9:00 a.m., Chicago time, at a closing (the "Closing" ) on April 29, 2004 or on such other Business Day thereafter on or prior to May 10, 2004 as may be agreed upon by the Company and you and the Other Purchasers. At the Closing the Company will deliver to you the Notes to be purchased by you in the form of a single Note (or such greater number of Notes in denominations of at least $100,000 as you may request) dated the date of the Closing and registered in your name (or in the name of your nominee), against delivery by you to the Company or its order of immediately available funds in the amount of the purchase price therefor by wire transfer of

 




 

immediately available funds for the account of the Company to account number 102 121 at The Bank of New York, ABA No. 021 000 018. If at the Closing the Company shall fail to tender such Notes to you as provided above in this Section 3, or any of the conditions specified in Section 4 shall not have been fulfilled to your satisfaction, you shall, at your election, be relieved of all further obligations under this Agreement, without thereby waiving any rights you may have by reason of such failure or such nonfulfillment. 4. CONDITIONS TO CLOSING.           Your obligation to purchase and pay for the Notes to be sold to you at the Closing is subject to the fulfillment to your satisfaction, prior to or at the Closing, of the following conditions: 4.1. Representations and Warranties.           The representations and warranties of the Company in this Agreement shall be correct when made and at the time of the Closing. 4.2. Performance; No Default.           The Company shall have performed and complied with all agreements and conditions contained in this Agreement required to be performed or complied with by it prior to or at the Closing, and after giving effect to the issue and sale of the Notes (and the application of the proceeds thereof as contemplated by Schedule 5.14) no Default or Event of Default shall have occurred and be continuing. Neither the Company nor any Subsidiary shall have entered into any transaction since the date of the Memorandum that would have been prohibited by Sections 10.4, 10.5 or 10.6 hereof had such Sections applied since such date. 4.3. Compliance Certificates.           (a) Officer’s Certificate . The Company shall have delivered to you an Officer’s Certificate, dated the date of the Closing, certifying that the conditions specified in Sections 4.1, 4.2 and 4.9 have been fulfilled.           (b) Secretary’s Certificate . The Company shall have delivered to you a certificate certifying as to the resolutions attached thereto and other corporate proceedings relating to the authorization, execution and delivery of the Notes and this Agreement. 4.4. Opinions of Counsel.           You shall have received opinions in form and substance satisfactory to you, dated the date of the Closing ( a ) from Shearman & Sterling LLP, special counsel for the Company, and James S. Hamman, Jr., General Counsel of the Company, covering the respective matters set forth in Exhibit 4.4(a) (and the Company hereby instructs its counsel to deliver such opinion to you) and ( b ) from Gardner Carton & Douglas LLP, special counsel for you and the Other Purchasers (the "Special Counsel" ) in connection with such transactions, substantially in the form set forth in Exhibit 4.4(b) and covering such other matters incident to such transactions as you may reasonably request.

2




 

4.5. Purchase Permitted By Applicable Law, etc.           On the date of the Closing your purchase of Notes shall ( i ) be permitted by the laws and regulations of each jurisdiction to which you are subject, without recourse to provisions (such as Section 1405(a)(8) of the New York Insurance Law) permitting limited investments by insurance companies without restriction as to the character of the particular investment, ( ii ) not violate any applicable law or regulation (including, without limitation, Regulation G, T or X of the Board of Governors of the Federal Reserve System) and ( iii ) not subject you to any tax, penalty or liability under or pursuant to any applicable law or regulation, which law or regulation was not in effect on the date hereof. If requested by you, you shall have received an Officer’s Certificate certifying as to such matters of fact as you may reasonably specify to enable you to determine whether such purchase is so permitted. 4.6. Sale of Other Notes.           Contemporaneously with the Closing the Company shall sell to the Other Purchasers and the Other Purchasers shall purchase the Notes to be purchased by them at the Closing as specified in Schedule A. 4.7. Payment of Special Counsel Fees.           Without limiting the provisions of Section 15.1, the Company shall have paid on or before the Closing the reasonable fees, charges and disbursements of the Special Counsel to the extent reflected in a statement of the Special Counsel rendered to the Company at least two Business Days prior to the Closing; provided that the Special Counsel has provided to the Company a written estimate of such fees at least five days prior to the Closing. 4.8. Private Placement Number.           A Private Placement number issued by Standard & Poor’s CUSIP Service Bureau (in cooperation with the Securities Valuation Office of the National Association of Insurance Commissioners) shall have been obtained for the Notes. 4.9. Changes in Corporate Structure.           Except as specified in Schedule 4.9, the Company shall not have changed its jurisdiction of incorporation or been a party to any merger or consolidation and shall not have succeeded to all or any substantial part of the liabilities of any other entity, at any time following the date of the most recent financial statements referred to in Schedule 5.5. 4.10. Proceedings and Documents.           All corporate and other proceedings in connection with the transactions contemplated by this Agreement and all documents and instruments incident to such transactions shall be satisfactory to you and the Special Counsel, and you and the Special Counsel shall have received all such counterpart originals or certified or other copies of such documents as you or they may reasonably request.

3




 

5. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.           The Company represents and warrants to you that: 5.1. Organization; Power and Authority.           The Company is a corporation duly organized, validly existing and in good standing under the laws of its jurisdiction of incorporation, and is duly qualified as a foreign corporation and is in good standing in each jurisdiction in which such qualification is required by law, other than those jurisdictions as to which the failure to be so qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has the corporate power and authority to own or hold under lease the properties it purports to own or hold under lease, to transact the business it transacts and proposes to transact, to execute and deliver this Agreement and the Notes and to perform the provisions hereof and thereof. The Company possesses all licenses, registrations and authorizations from and with any Governmental Authority, self-regulatory organization or securities exchange necessary or material to the conduct of its business as presently conducted, other than where the failure to possess such licenses, registrations or authorizations would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 5.2. Authorization, etc.           This Agreement and the Notes have been duly authorized by all necessary corporate action on the part of the Company, and this Agreement constitutes, and upon execution and delivery thereof each Note will constitute, a legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by ( i ) applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and ( ii ) general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). 5.3. Disclosure.           The Company, through its authorized agent, Merrill Lynch, Pierce, Fenner & Smith Incorporated, has delivered to you and each Other Purchaser a copy of a Private Placement Memorandum, dated March 2004 (the "Memorandum" ), relating to the transactions contemplated hereby. The Memorandum fairly describes, in all material respects, the general nature of the business and principal properties of the Company and its Subsidiaries. Except as disclosed in Schedule 5.3, this Agreement, the Memorandum, the documents, certificates or other writings delivered to you by or on behalf of the Company in connection with the transactions contemplated hereby and the financial statements listed in Schedule 5.5, taken as a whole, do not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading in light of the circumstances under which they were made. Except as disclosed in the Memorandum or as expressly described in Schedule 5.3, or in one of the documents, certificates or other writings identified therein, or in the financial statements listed in Schedule 5.5, since December 31, 2003 there has been no change in the financial condition, operations, business or properties of the Company or any Subsidiary except changes that individually or in the aggregate would not reasonably be expected to have a Material Adverse

4




 

Effect. There is no fact known to the Company that could reasonably be expected to have a Material Adverse Effect that has not been set forth herein or in the Memorandum or in the other documents, certificates and other writings delivered to you by or on behalf of the Company specifically for use in connection with the transactions contemplated hereby. Notwithstanding anything to the contrary in this Agreement, the Company makes no representation with respect to any projected financial information contained in the Memorandum, except that such projected financial information is based on information that the Company believes to be accurate as of the date hereof and was calculated in a manner that the Company believes to be reasonable. 5.4. Organization and Ownership of Shares of Subsidiaries; Affiliates.           (a) Schedule 5.4 contains (except as noted therein) complete and correct lists ( i ) of the Company’s Subsidiaries, showing, as to each Subsidiary, the correct name thereof, the jurisdiction of its organization, and the percentage of shares of each class of its capital stock or similar equity interests outstanding owned by the Company and each other Subsidiary, ( ii ) of the Company’s Affiliates, other than Subsidiaries, and ( iii ) of the Company’s directors and senior officers.           (b) All of the outstanding shares of capital stock or similar equity interests of each Subsidiary shown in Schedule 5.4 as being owned by the Company and its Subsidiaries have been validly issued, are fully paid and nonassessable and are owned by the Company or another Subsidiary free and clear of any Lien (except as otherwise disclosed in Schedule 5.4).           (c) Each Subsidiary identified in Schedule 5.4 is a corporation or other legal entity duly organized, validly existing and in good standing under the laws of its jurisdiction of organization, and is duly qualified as a foreign corporation or other legal entity and is in good standing in each jurisdiction in which such qualification is required by law, other than those jurisdictions as to which the failure to be so qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Each such Subsidiary has the corporate or other power and authority to own or hold under lease the properties it purports to own or hold under lease and to transact the business it transacts and proposes to transact. Each Subsidiary possesses all licenses, registrations and authorizations from and with any Governmental Authority, self-regulatory organization or securities exchange necessary or material to the conduct of its business as presently conducted, other than where the failure to possess such licenses, registrations or authorizations would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.           (d) No Subsidiary is a party to, or otherwise subject to any legal restriction or any agreement (other than this Agreement, the agreements listed on Schedule 5.4 and customary limitations imposed by corporate law statutes or regulatory requirements imposed by the Commission, the National Association of Securities Dealers, Inc. or other regulatory authorities) restricting the ability of such Subsidiary to pay dividends out of profits or make any other similar distributions of profits to the Company or any of its Subsidiaries that owns outstanding shares of capital stock or similar equity interests of such Subsidiary.

5




 

5.5. Financial Statements.           (a) The Company has delivered to each Purchaser copies of the audited financial statements of the Company and its Subsidiaries listed on Schedule 5.5. All of said audited financial statements (including in each case the related schedules and notes) fairly present in all material respects the consolidated financial position of the Company and its Subsidiaries as of the respective dates specified in such Schedule and the consolidated results of their operations and cash flows for the respective periods so specified and have been prepared in accordance with GAAP consistently applied throughout the periods involved except as set forth in the notes thereto.           (b) The Company has delivered to each Purchaser copies of the unaudited pro forma financial statements of the Company and its Subsidiaries listed on Schedule 5.5. All of said unaudited pro forma financial statements fairly present in all material respects the information contained therein, and the assumptions used in the preparation thereof are reasonable. 5.6. Compliance with Laws, Other Instruments, etc.           The execution, delivery and performance by the Company of this Agreement and the Notes will not ( i ) contravene, result in any breach of, or constitute a default under, or result in the creation of any Lien in respect of any property of the Company or any Subsidiary under, any indenture, mortgage, deed of trust, loan, purchase or credit agreement, lease, corporate charter or by-laws, or any other agreement or instrument to which the Company or any Subsidiary is bound or by which the Company or any Subsidiary or any of their respective properties may be bound or affected, ( ii ) conflict with or result in a breach of any of the terms, conditions or provisions of any order, judgment, decree, or ruling of any court, arbitrator or Governmental Authority applicable to the Company or any Subsidiary or ( iii ) violate any provision of any statute or other rule or regulation of any Governmental Authority applicable to the Company or any Subsidiary, except, in each case, as would not reasonably be expected to result in a Material Adverse Effect. 5.7. Governmental Authorizations, etc.           No consent, approval or authorization of, or registration, filing or declaration with, any Governmental Authority is required in connection with the execution, delivery or performance by the Company of this Agreement or the Notes, except such as have already been obtained or made, which are disclosed in Schedule 5.7. 5.8. Litigation; Observance of Agreements, Statutes and Orders.           (a) Except as disclosed in Schedule 5.8, there are no actions, suits or proceedings pending or, to the knowledge of the Company, threatened against or affecting the Company or any Subsidiary or any property of the Company or any Subsidiary in any court or before any arbitrator of any kind or before or by any Governmental Authority that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect.           (b) Neither the Company nor any Subsidiary is in default under any term of any agreement or instrument to which it is a party or by which it is bound, or any order, judgment,

6




 

decree or ruling of any court, arbitrator or Governmental Authority or is in violation of any applicable law, ordinance, rule or regulation (including Environmental Laws and the USA Patriot Act) of any Governmental Authority, which default or violation, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. 5.9. Taxes.           The Company and its Subsidiaries have filed all tax returns that are required to have been filed in any jurisdiction, and have paid all taxes shown to be due and payable on such returns and all other taxes and assessments levied upon them or their properties, assets, income or franchises, to the extent such taxes and assessments have become due and payable and before they have become delinquent, except for any taxes and assessments ( i ) the amount of which is not individually or in the aggregate Material or ( ii ) the amount, applicability or validity of which is currently being contested in good faith by appropriate proceedings and with respect to which the Company or a Subsidiary, as the case may be, has established adequate reserves in accordance with GAAP. The Company knows of no basis for any other tax or assessment that would reasonably be expected to have a Material Adverse Effect. The charges, accruals and reserves on the books of the Company and its Subsidiaries in respect of Federal, state or other taxes for all fiscal periods are adequate. The Company has never been audited by the Internal Revenue Service. 5.10. Title to Property; Leases.           The Company and its Subsidiaries have good and sufficient title to their respective Material properties, including all such properties reflected in the most recent audited balance sheet referred to in Section 5.5 or purported to have been acquired by the Company or any Subsidiary after said date (except as sold or otherwise disposed of in the ordinary course of business), in each case free and clear of Liens prohibited by this Agreement. All Material leases of the Company and its Subsidiaries are valid and subsisting and are in full force and effect in all material respects. 5.11. Licenses, Permits, etc.           Except as disclosed in Schedule 5.11,      (a) the Company and its Subsidiaries own or possess all Material licenses, permits, franchises, authorizations, patents, copyrights, service marks, trademarks and trade names, or rights thereto without known conflict with the rights of others;      (b) to the knowledge of the Company, no product of the Company infringes in any material respect any license, permit, franchise, authorization, patent, copyright, service mark, trademark, trade name or other right owned by any other Person; and      (c) to the knowledge of the Company, there is no Material violation by any Person of any right of the Company or any of its Subsidiaries with respect to any patent, copyright, service mark, trademark, trade name or other right owned or used by the Company or any of its Subsidiaries.

7




 

5.12. ERISA.           (a) Neither the Company nor any ERISA Affiliate has any Pension Plan or Multiemployer Plan.           (b) The expected postretirement medical benefit obligation (determined as of the last day of the Company’s most recently ended fiscal year in accordance with Financial Accounting Standards Board Statement No. 106, without regard to liabilities attributable to continuation coverage mandated by Section 4980B of the Code) of the Company and its Subsidiaries is not Material.           (c) The execution and delivery of this Agreement and the issuance and sale of the Notes hereunder will not involve any transaction that is subject to the prohibitions of Section 406(a)(1)(A)-(D) of ERISA or in connection with which a tax would be imposed pursuant to Section 4975(c)(1)(A)-(D) of the Code. The representation by the Company in the first sentence of this Section 5.12(c) is made in reliance upon and subject to the accuracy of your representation in Section 6.2 as to the sources of the funds used to pay the purchase price of the Notes to be purchased by you. 5.13. Private Offering by the Company.           Neither the Company nor anyone authorized to act on its behalf has offered the Notes or any similar securities for sale to, or solicited any offer to buy any of the same from, or otherwise approached or negotiated in respect thereof with, any person other than you, the Other Purchasers and not more than 125 other Institutional Investors, each of which has been offered the Notes at a private sale for investment. Neither the Company nor anyone authorized to act on its behalf has taken, or will take, any action that would subject the issuance or sale of the Notes to the registration requirements of Section 5 of the Securities Act. 5.14. Use of Proceeds; Margin Regulations.           The Company will apply the proceeds of the sale of the Notes for general corporate purposes, to make investments in new products of the Company and its Subsidiaries and to repay indebtedness as set forth in Schedule 5.14. Other than as contemplated by the Memorandum, no part of the proceeds from the sale of the Notes will be used, directly or indirectly, for the purpose of buying or carrying any margin stock within the meaning of Regulation U of the Board of Governors of the Federal Reserve System (12 CFR 221). No part of the proceeds from the sale of the Notes will be used, directly or indirectly, for the purpose of buying or carrying or trading in any securities under such circumstances as to involve the Company in a violation of Regulation X of said Board (12 CFR 224) or to involve any broker or dealer in a violation of Regulation T of said Board (12 CFR 220). Margin stock does not constitute more than 24.9% of the value of the consolidated assets of the Company and its Subsidiaries, and the Company does not have any present intention that margin stock will constitute more than 24.9% of the value of such assets. As used in this Section, the terms "margin stock" and "purpose of buying or carrying" shall have the meanings assigned to them in said Regulation U.

8




 

5.15. Existing Indebtedness; Future Liens.           (a) Except as described therein, Schedule 5.15 sets forth a complete and correct list of all outstanding Indebtedness of the Company and its Subsidiaries as of February 29, 2004, since which date there has been no Material change in the amounts, interest rates, sinking funds, installment payments or maturities of the Indebtedness of the Company or its Subsidiaries. Neither the Company nor any Subsidiary is in default and no waiver of default is currently in effect, in the payment of any principal or interest on any Indebtedness of the Company or such Subsidiary and no event or condition exists with respect to any Indebtedness of the Company or any Subsidiary that would permit (or that with notice or the lapse of time, or both, would permit) one or more Persons to cause such Indebtedness to become due and payable before its stated maturity or before its regularly scheduled dates of payment.           (b) Except as disclosed in Schedule 5.15, neither the Company nor any Subsidiary has agreed or consented to cause or permit in the future (upon the happening of a contingency or otherwise) any of its property, whether now owned or hereafter acquired, to be subject to a Lien not permitted by Section 10.5. 5.16. Foreign Assets Control Regulations, etc.           To the knowledge of the Company, neither the sale of the Notes by the Company hereunder nor its use of the proceeds thereof will violate (a) the Trading with the Enemy Act, as amended, (b) any of the foreign assets control regulations of the United States Treasury Department (31 CFR, Subtitle B, Chapter V, as amended) or any enabling legislation or executive order relating thereto, (c) the Anti-Terrorism Order or (d) the United States Foreign Corrupt Practices Act of 1997, as amended. Without limiting the foregoing, neither the Company nor any Subsidiary (i) is a blocked person described in Section 1 of the Anti-Terrorism Order or (ii) to the knowledge of the Company, engages in any dealings or transactions, or is otherwise associated, with any such person. 5.17. Status under Certain Statutes.           The Company is not an "investment company" as defined in the Investment Company Act of 1940, as amended, nor is it subject to regulation under the Public Utility Holding Company Act of 1935, as amended, the Interstate Commerce Act, as amended by the ICC Termination Act, as amended, or the Federal Power Act, as amended. 5.18. Environmental Matters.           Neither the Company nor any Subsidiary has knowledge of any claim or has received any notice of any claim, and no proceeding has been instituted raising any claim against the Company or any of its Subsidiaries or any of their respective real properties now or formerly owned, leased or operated by any of them or other assets, alleging any damage to the environment or violation of any Environmental Laws, except, in each case, such as would not reasonably be expected to result in a Material Adverse Effect. Except as otherwise disclosed to you in writing,      (a) neither the Company nor any Subsidiary has knowledge of any facts which would give rise to any claim, public or private, of violation of Environmental Laws or damage to the environment emanating from, occurring on or in any way related to real

9




 

properties now or formerly owned, leased or operated by any of them or to other assets or their use, except, in each case, such as would not reasonably be expected to result in a Material Adverse Effect;      (b) neither the Company nor any of its Subsidiaries has stored any Hazardous Materials on real properties now or formerly owned, leased or operated by any of them and has not disposed of any Hazardous Materials in a manner contrary to any Environmental Laws in each case in any manner that would reasonably be expected to result in a Material Adverse Effect; and      (c) all buildings on all real properties now owned, leased or operated by the Company or any of its Subsidiaries are in compliance with applicable Environmental Laws, except where failure to comply would not reasonably be expected to result in a Material Adverse Effect. 5.19. Pari Passu Ranking.           As of the date of this Agreement, the Indebtedness evidenced by the Notes ranks pari passu in right of payment with all of the Company’s outstanding unsecured senior Indebtedness. 6. REPRESENTATIONS OF THE PURCHASER. 6.1. Purchase for Investment.           You represent that you are purchasing the Notes for your own account or for one or more separate accounts maintained by you or for the account of one or more pension or trust funds and not with a view to the distribution thereof, provided that the disposition of your or their property shall at all times be within your or their control. You understand that the Notes have not been registered under the Securities Act and may be resold only if registered pursuant to the provisions of the Securities Act or if an exemption from registration is available, except under circumstances where neither such registration nor such an exemption is required by law, and that the Company is not required to register the Notes. 6.2. Source of Funds.           You represent that at least one of the following statements is, and will remain at all times, an accurate representation as to each source of funds (a "Source" ) to be used by you to pay the purchase price of, and to be attributed to the holding of, the Notes to be purchased and held by you hereunder:      (a) the Source does not include "plan assets" (within the meaning of the United States Department of Labor Regulation 29 C.F.R. Section 2510.3-101) of any (i) employee benefit plan (as defined in Section 3(3) of ERISA) that is subject to Title I of ERISA, (ii) plan described in Section 4975(e)(1) of the Code, (iii) entity whose assets include "plan assets" by reason of an employee benefit plan’s or plan’s investment in such entity, or (iv) foreign plan, governmental plan (as defined in Section 3(32) of ERISA) or church plan (as defined in Section 3(33) of ERISA) that is subject to any

10




 

federal, state, local or foreign law or regulation that is substantially similar to Section 406 of ERISA or Section 4975 of the Code (a "Similar Law" ); or      (b) the Source is one or more employee benefit plans, or a separate account or trust fund comprised of one or more employee benefit plans, and the purchase and holding of the Notes do not and will not result in a nonexempt prohibited transaction under Section 4975 of the Code or Section 406 of ERISA, or any Similar Law; or      (c) the Source is an insurance company pooled separate account and Prohibited Transaction Class Exemption ( "PTCE" ) 90-1 applies to exempt the purchase and holding of the Notes; or      (d) the Source is an insurance company general account and PTCE 95-60 applies to exempt the purchase and holding of the Notes; or      (e) the Source is a bank collective investment fund and PTCE 91-38 applies to exempt the purchase and holding of the Notes; or      (f) the Source constitutes assets of an investment fund managed by an "in-house asset manager" within the meaning of PTCE 96-23 (the "INHAM Exemption" ) and the INHAM Exemption applies to exempt the purchase and holding of the Notes; or      (g) the Source constitutes assets of an investment fund managed by a "qualified professional asset manager" within the meaning of PTCE 84-14 (the "QPAM Exemption" ) and the QPAM Exemption applies to exempt the purchase and holding of the Notes. 7. INFORMATION AS TO COMPANY. 7.1. Financial and Business Information.           The Company shall deliver to each holder of Notes that is an Institutional Investor:      (a) Quarterly Statements – within 60 days after the end of each quarterly fiscal period in each fiscal year of the Company (other than the last quarterly fiscal period of each such fiscal year), duplicate copies of,      (i) a consolidated balance sheet of the Company and its Subsidiaries as at the end of such quarter, and      (ii) consolidated statements of income, changes in shareholders’ equity and cash flows of the Company and its Subsidiaries, for such quarter and (in the case of the second and third quarters) for the portion of the fiscal year ending with such quarter, setting forth in each case in comparative form the figures for the corresponding periods in the previous fiscal year, all in reasonable detail, prepared in accordance with GAAP applicable to quarterly financial statements generally, and certified by a Senior Financial

11




 

Officer as fairly presenting, in all material respects, the financial position of the companies being reported on and their results of operations and cash flows, subject to changes resulting from year-end adjustments, provided that, if the Company is required to file reports with the Commission pursuant to Section 13(a) or Section 15(d) under the Exchange Act, delivery within the time period specified above of copies of the Company’s Quarterly Report on Form 10-Q prepared in compliance with the requirements therefor and filed with the Commission shall be deemed to satisfy the requirements of this Section 7.1(a);      (b) Annual Statements – within 105 days after the end of each fiscal year of the Company, duplicate copies of,      (i) a consolidated balance sheet of the Company and its Subsidiaries, as at the end of such year, and      (ii) consolidated statements of income, changes in shareholders’ equity and cash flows of the Company and its Subsidiaries, for such year, setting forth in each case in comparative form the figures for the previous fiscal year, all in reasonable detail, prepared in accordance with GAAP, and accompanied by an opinion thereon of independent certified public accountants of recognized national standing, which opinion shall state that such financial statements present fairly, in all material respects, the financial position of the companies being reported upon and their results of operations and cash flows and have been prepared in conformity with GAAP, and that the examination of such accountants in connection with such financial statements has been made in accordance with generally accepted auditing standards, and that such audit provides a reasonable basis for such opinion in the circumstances; provided that, if the Company is required to file reports with the Commission pursuant to Section 13(a) or Section 15(d) under the Exchange Act, the delivery within the time period specified above of the Company’s Annual Report on Form 10-K for such fiscal year (together with the Company’s annual report to shareholders, if any, prepared pursuant to Rule 14a-3 under the Exchange Act) prepared in accordance with the requirements therefor and filed with the Commission shall be deemed to satisfy the requirements of this Section 7.1(b);      (c) SEC and Other Reports – if the Company is required to file reports with the Commission pursuant to Section 13(a) or Section 15(d) under the Exchange Act, promptly upon their becoming available, one copy of ( i ) each financial statement, report, notice or proxy statement sent by the Company or any Subsidiary to public securities holders generally, and ( ii ) each regular or periodic report, each registration statement (without exhibits except as expressly requested by such holder), and each prospectus and all amendments thereto filed by the Company or any Subsidiary with the Commission and of all press releases and other statements made available generally by the Company or any Subsidiary to the public concerning developments that are Material;      (d) Notice of Default or Event of Default – promptly, and in any event within five days after a Responsible Officer becoming aware of the existence of any Default or Event of Default or that any Person has given any notice or taken any action with respect to a

12




 

claimed default hereunder or that any Person has given any notice or taken any action with respect to a claimed default of the type referred to in Section 11(f), a written notice specifying the nature and period of existence thereof and what action the Company is taking or proposes to take with respect thereto;      (e) ERISA Matters – promptly, and in any event within five days after a Responsible Officer becoming aware of any of the following, a written notice setting forth the nature thereof and the action, if any, that the Company or an ERISA Affiliate proposes to take with respect thereto:           (i) with respect to any Pension Plan, any reportable event, as defined in section 4043(c) of ERISA and the regulations thereunder, for which notice thereof has not been waived pursuant to such regulations as in effect on the date hereof; or           (ii) the taking by the PBGC of steps to institute, or the threatening by the PBGC of the institution of, proceedings under section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Pension Plan, or the receipt by the Company or any ERISA Affiliate of a notice from a Multiemployer Plan that such action has been taken by the PBGC with respect to such Multiemployer Plan; or           (iii) any event, transaction or condition that could result in the incurrence of any liability by the Company or any ERISA Affiliate pursuant to Title I or IV of ERISA or the penalty or excise tax provisions of the Code relating to employee benefit plans, or in the imposition of any Lien on any of the rights, properties or assets of the Company or any ERISA Affiliate pursuant to Title I or IV of ERISA or such penalty or excise tax provisions, if such liability or Lien, taken together with any other such liabilities or Liens then existing, could reasonably be expected to have a Material Adverse Effect;      (f) Notices from Governmental Authority – promptly, and in any event within 30 days of receipt


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more